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Original Article

Utility of inflammatory markers to predict adverse outcome
in acute pancreatitis: A retrospective study in a single
academic center
Mohamad Mubder, Banreet Dhindsa, Danny Nguyen, Syed Saghir, Chad Cross1, Ranjit Makar2, Gordon Ohning2
Departments of Internal Medicine and 2Gastroenterology and Hepatology, School of Medicine, University of Nevada-Las Vegas,
1
School of Medicine, University of Nevada-Las Vegas, Las Vegas, NV, United States

Abstract

Background/Aim: Acute pancreatitis (AP) is a commonly encountered emergency where early identification
of complicated cases is important. Inflammatory markers like lymphocyte to monocyte ratio (LMR) and
neutrophil to lymphocyte ratio (NLR) are simple and readily available markers. In this study, we evaluated
the utility of these markers in the early identification of patients with complicated AP.
Patients and Methods: All patients with a diagnosis of AP admitted to the University Medical Center in
Las Vegas/Nevada between August 2015 and September 2018 were identified using ICD‑10 codes. Medical
records were reviewed retrospectively. Epidemiological measures and their associated confidence intervals
were calculated using MedCalc (v. 18).
Results: The LMR showed a significant difference between groups, with the non‑complicated cases
consistently higher than the complicated cases but without significant temporal differences. The NLR showed
a significant difference with a significant temporal relation. Using the bound of the 95% confidence interval
separating the two groups, LMR <2 was found to be associated with a complicated case and NLR >10.5
was suggestive of a complicated case. High specificity (85–92%) with low sensitivity (23–69%) was noted;
hence, these cut points were very good at discerning non‑complicated cases.
Conclusion: Our data show persistently low LMR that is associated with severe AP and a value of <2.0
can be used clinically to predict severe AP on admission. It also shows that elevated NLR is associated
with complicated AP and prolonged hospital stay with a value >10.5 that can be used to predict severe
complicated AP and to monitor response to treatment over time.
Keywords: Acute complicated pancreatitis, lymphocytes to monocyte ratio, neutrophil to lymphocyte ratio
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INTRODUCTION

Acute pancreatitis (AP) is a common inflammatory
condition characterised by local and systemic inflammation
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with symptoms ranging from asymptomatic or mild disease
to severe systemic inflammatory response complicated by
persistent organ failure and possibly death.[1‑3]
This is an open access journal, and articles are distributed under the terms of the
Creative Commons Attribution‑NonCommercial‑ShareAlike 4.0 License, which
allows others to remix, tweak, and build upon the work non‑commercially, as long
as appropriate credit is given and the new creations are licensed under the identical
terms.
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Therefore, it is crucial to identify patients with increased
risk of developing severe disease and start evidence‑based
intensive care to prevent the development of severe
complications and reduce morbidity and mortality.
Several scoring systems have been developed to stratify
the severity of AP, but they have their own limitations,
namely, Ranson’s and Glasgow score require data that are
not routinely available at presentation and need long time
to complete. The acute physiology and chronic health
examination (APACHE‑II) that was developed to be used
in critical care setting requires multiple parameters that are
also not available at the time of presentations. Sequential
organ failure assessment (SOFA) has been developed but
is still suitable only in the intensive care setting and not for
routine use in all patients presenting with AP. Therefore,
a simplified serum biomarker that is readily available
on admission with good sensitivity is required for the
early identification and treatment of severe AP to lower
morbidity and mortality.[4‑6]
Neutrophil to lymphocyte ratio (NLR) and lymphocytes to
monocyte ratio (LMR) have shown values in predicting the
disease prognosis of multiple malignancies and systemic
inflammatory diseases.[7‑10] These parameters are readily
available upon admission through a simple complete blood
count. Few studies have looked into using these values to
predict the disease severity in case of acute pancreatitis.
Our study aims to investigate the validity of using these
markers in predicting the disease severity and outcome in
patients with acute pancreatitis, in addition to treatment
response over the first 48 hours. It also aims to determine
the optimal cut‑off value that would allow the early
recognition of patients with the tendency to develop severe
AP of multiple etiologies.
PATIENTS AND METHODS

This is a retrospective chart review of patients admitted
to the academic medical center with a diagnosis of AP
between August 2015 and September 2018. Approval from
IRB and Ethics committee was obtained on November
5th, 2018. The patients were identified using ICD‑10
codes. The patients were labeled as either complicated
or non‑complicated groups based on the hospital
course and clinical outcome. Different parameters and
variables were calculated and compared between the two
groups (complicated vs. non‑complicated) including LMR
and NLR on admission and at 24 and 48 hours. Using
revised Atlanta classification, the patients with moderate
and severe AP were included in the complicated group and
mild AP in the non‑complicated group. Clinical course and
Saudi Journal of Gastroenterology | Volume 26 | Issue 4 | July-August 2020

outcome were also considered including ICU admission
and mortality rate.
Descriptive statistics for all variables were calculated
to determine the mean, SD, and range of values. In
addition, the measures of skewness and kurtosis were
evaluated to discern potential deviations from normal
assumptions. Independent‑sample t‑tests were used to
compare the demographic variables of age and total
length‑of‑stay (LOS). Of particular interest was the
potential of significant differences owing to time and
complication status. To address this question, RM‑ANOVA
was utilised. The RM‑ANOVA was developed for a
within‑between design, with Greenhouse–Geisser
estimates reported. To assess potential non‑normality,
both observed data and a rank‑based transformation
of the data were employed; the statistical results were
identical in both cases and, hence, the parametric results
are provided. As a final analysis, we investigated the
potential cut‑points of significant biomarkers for clinical
use. Cut points were established using the bound of the
95% confidence limit separating the complicated cases
from non‑complicated cases. Using these results, the
predicted complicated cases were compared to clinically
known complicated cases in an epidemiological analysis to
determine the sensitivity, specificity, PPV and NPV, along
with their Clopper–Pearson or logit confidence intervals.
Descriptive statistics and models were calculated using
the SPSS software (IBM; v. 25). Epidemiological measures
and their associated confidence intervals were calculated
using MedCalc (v. 18).
RESULTS

The summary statistics for demographic and clinical
variables for each time period are provided in Table 1.
The mean age of patients was not different between the
complicated and non‑complicated cases (t = 0.26, P = 0.799)
but the total LOS did differ, with complicated cases
representing over twice the total LOS as non‑complicated
cases (t = 8.18, P < 0.001).
The LMR showed a significant difference between the
groups, with the non‑complicated cases consistently higher
than the complicated cases (F = 11.34, P = 0.001) and there
were no significant temporal differences (F = 1.48, P = 0.232)
[Figure 1]. The NLR showed a significant difference
between the groups, with the non‑complicated cases
consistently lower than the complicated cases (F = 23.11,
P < 0.001). In addition, there was a significant complication
status‑by‑time interaction (F = 3.88, P = 0.040), with
significant differences notable at both post‑admission
217
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Table 1: Descriptive statistics for demographic and clinical measures
Variable
n
Age
ICU LOS
Total LOS
Lipase Admission
Lipase Day 1
Lipase Day 2
WBC Admission
WBC Day 1
WBC Day 2
Hematocrit Admission
Hematocrit Day 1
Hematocrit Day 2
Platelets Admission
Platelets Day 1
Platelets Day 2
RDW Admission
RDW Day 1
RDW Day 2
Neutrophil Admission
Neutrophil Day 1
Neutrophil Day 2
Lymphocytes Admission
Lymphocytes Day 1
Lymphocytes Day 2
Neutrophil Admission
Neutrophil Day 1
Neutrophil Day 2
ABS Lymphocyte Admission
ABS Lymphocyte Day 1
ABS Lymphocyte Day 2
ABS Monocyte Admission
ABS Monocyte Day 1
ABS Monocyte Day 2
LMR Admission
LMR Day 1
LMR Day 2
NLR Admission
NLR Day 1
NLR Day 2

198
1
193
197
122
102
198
187
164
198
187
165
198
187
165
195
186
165
184
131
99
184
131
99
178
131
99
178
130
96
178
130
96
178
130
65
178
130
38

Non‑complicated Cases
Min
Max
Mean
14.0
2.0
1.0
76.0
13.0
5.0
2.4
2.2
1.9
22.2
9.5
12.6
70.0
56.0
36.9
11.4
11.9
12.0
44.5
18.0
38.0
1.8
1.9
0.8
1.3
18.0
38.0
0.2
0.2
0.3
0.1
0.1
0.2
0.2
0.3
0.4
0.4
0.9
0.9

87.0
2.0
13.0
16341.0
2079.0
1017.0
28.0
25.0
21.7
56.2
54.1
48.7
888.0
1600.0
1888.0
23.4
23.9
24.2
97.0
92.1
97.0
46.8
69.5
43.1
24.5
92.1
97.0
13.7
26.7
3.7
9.9
15.2
7.0
14.9
12.0
8.0
54.0
47.0
32.0

46.5
2.0
4.1
1152.5
527.3
177.0
10.8
9.5
8.8
42.7
38.2
36.2
230.7
200.9
196.5
14.5
14.5
14.5
77.0
74.6
71.8
14.6
16.2
17.8
8.6
74.6
71.8
1.5
1.5
1.4
0.8
0.8
0.8
2.4
2.3
2.4
9.1
7.9
5.4

SD

n

Min

15.35

41
25
39
41
22
22
41
41
40
41
41
40
41
41
40
41
41
40
40
34
31
40
34
29
39
34
31
39
32
28
39
32
29
39
32
22
39
31
15

19.0
1.0
2.0
70.0
63.0
10.0
4.5
3.4
3.4
19.9
23.2
21.3
80.0
55.0
37.0
12.4
12.4
12.7
53.0
53.5
49.7
2.2
1.9
1.0
2.4
53.5
49.7
0.2
0.2
0.2
0.3
0.4
0.1
0.2
0.3
0.2
1.4
1.8
2.5

2.32
1324.15
559.97
183.75
4.50
4.08
3.74
5.77
5.78
5.51
95.61
134.95
164.37
1.75
1.70
1.78
11.92
12.98
12.75
9.38
10.87
10.28
4.33
12.98
12.75
1.41
2.32
0.64
0.98
1.31
0.71
1.84
1.69
1.32
9.11
7.31
5.61

Complicated Cases
Max
Mean
74.0
22.0
51.0
5000.0
2079.0
1908.0
28.3
27.9
30.8
57.6
56.3
48.9
776.0
542.0
540.0
25.6
40.3
166.9
92.0
95.0
95.0
37.7
30.0
37.8
25.6
95.0
95.0
6.5
26.1
3.3
2.9
6.9
2.9
5.4
4.5
9.0
45.0
51.0
98.0

47.1
8.3
10.6
1204.6
653.1
424.5
13.8
12.4
11.6
43.4
39.4
36.3
247.3
182.9
166.7
15.2
15.7
19.4
80.6
79.7
79.6
11.2
9.6
11.0
11.4
79.7
79.6
1.4
1.7
1.1
1.0
1.1
0.9
1.6
1.2
1.5
13.1
16.5
23.6

SD
13.44
7.00
9.85
943.78
526.19
439.04
6.03
5.72
5.79
8.64
8.83
6.58
138.86
100.85
97.29
2.55
4.34
24.28
8.86
12.37
11.62
7.88
8.28
9.01
5.55
12.37
11.62
1.21
4.48
0.68
0.49
1.14
0.57
1.14
0.96
1.89
11.81
12.47
25.67

Figure 1: Estimated marginal means through time for LMR; 95% CI
are shown

Figure 2: Estimated marginal means through time for NLR; 95% CI
are shown

days [P < 0.05; Figure 2]. The RDW showed both a
significant change through time (F = 4.52, P = 0.034)
and a significant status‑by‑time interaction (F = 4.86,
P = 0.028), resulting in significant overlap between the
complicated and non‑complicated cases [Figure 3]. The

hematocrit measures showed a significant change through
time (F = 157.95, P < 0.001), but there was no significant
difference between status [F = 0.57, P = 0.451; Figure 4].
Similarly, for platelet counts, there was a significant change
through time (F = 13.48, P < 0.001), but there was no
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sensitivity was low, ranging from 23 to 69%; however,
the specificity was quite high, ranging from 85 to 92%.
Hence, these cut points were very good at discerning the
non‑complicated cases [Table 2].
DISCUSSION

Figure 3: Estimated marginal means through time for RDW; 95% CI
are shown

AP usually runs a mild clinical course without complications,
requiring only short‑term hospitalisation. However, about
20% of the patients develop a complicated clinical course.
These patients may suffer long‑term intensive care
admission and hospitalisation, and the need for invasive
interventions with significant mortality rates may occur
arising mainly from organ failure or infected pancreatic
necrosis.[11,12]
Haematological inflammatory markers have been widely
studied as prognostic markers in multiple inflammatory
and malignant conditions.[8,13‑16]

Figure 4: Estimated marginal means through time for haematocrit;
95% CI are shown

In this study, we evaluated the role of different haematological
markers in predicting the severity of AP, ICU admission,
development of organ failure and mortality rate in
our medical centre in Southern Nevada. Our goal was
to validate the value of using simple, readily available
parameters on admission to identify high‑risk patients
with the potential to develop severe disease which will
generate a higher degree of clinical suspicion for possible
complications and allows more aggressive care leading to
lower mortality rate and medical expenses. Compared to
conventional prediction scores, these markers are simple,
easily accessible and immediately available on admission and
can be used in facilities where other tests are not available.
The conventional scores such as APACHE II, BISAP and
Ranson’s criteria require multiple tests and imaging studies.
White cell count (WCC) is a common serum haematological
test that is routinely done in most medical and surgical
emergencies. It is already incorporated in many of the
current AP scoring systems; however, it is nonspecific and
cannot help in predicting poor outcome upon admission.[17]

Figure 5: Estimated marginal means through time for platelet counts;
95% CI are shown

difference between the complication status [F = 0.56,
P = 0.456; Figure 5].
The cut‑points for potential clinical use were investigated
using the bound of the 95% confidence interval separating
admission complicated and non‑complicated cases for the
two ratios that were found to be significant, namely LMR
(cut‑point <2 indicating a complicated case) and NLR
(cut‑point >10.5 indicating a complicated case). The overall
Saudi Journal of Gastroenterology | Volume 26 | Issue 4 | July-August 2020

Multiple studies have shown significance in the WCC
differentials as an indicator to poor prognosis in
multiple benign inflammatory and malignant conditions.
Neutrophils, lymphocytes and monocytes are the important
components of WCC. Neutrophils induce inflammation
and tissue destruction in AP via the activation of a cascade
of inflammatory cytokines (IL‑6, IL‑8, and TNF‑α),
proteolytic enzymes and oxygen‑free radicals.[18] An
increase in the neutrophil number corresponds with the
development of SIRS and progression to persistent organ
failure.[17]
219
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Table 2: Epidemiological analysis of potential cut‑off values and 95% confidence limits for complicated cases (LMR <2; NLR >10.5)
LMR Admission
LMR Day 1
LMR Day 2
NLR Admission
NLR Day 1
NLR Day 2

Sensitivity

Specificity

PPV

NPV

LR+

LR‑

22.6 (15.6, 31.0)
22.3 (18.8, 37.2)
37.3 (24.1, 51.9)
26.6 (16.3, 39.1)
35.3 (22.4, 49.9)
69.2 (38.6, 90.9)

88.2 (79.8, 99.0)
92.1 (82.4, 97.4)
91.7 (77.5, 98.3)
85.6 (79.0, 90.8)
88.2 (80.6, 93.6)
85.0 (70.2, 94.3)

71.8 (57.2, 82.9)
84.4 (68.7, 93.0)
86.4 (66.9, 95.2)
43.6 (30.6, 57.5)
58.1 (42.4, 72.3)
60 (39.7, 77.3)

46.1 (43.1, 49.1)
44.6 (41.2, 48.1)
50.8 (45.0, 56.6)
73.6 (70.4, 76.6)
74.6 (70.4, 78.5)
89.5 (78.8, 95.1)

1.9 (0.8, 31.0)
2.8 (1.1, 14.3)
4.5 (1.1, 30.5)
1.8 (0.8, 4.3)
3.0 (1.2, 7.8)
4.6 (1.3, 15.9)

0.9 (0.7, 1.0)
0.8 (0.6, 1.0)
0.7 (0.5, 1.0)
0.9 (0.7, 1.0)
0.7 (0.5, 1.0)
0.4 (0.1, 0.9)

Studies have shown that persistent lymphopenia indicates
poor prognosis and is an independent marker for
progressive inflammation, bacteremia and sepsis in
emergency department and critical care unit.[19,20]
In this study, we investigated the role of multiple
haematological inflammatory markers including NLR,
LMR, RDW, platelets count and haematocrit in predicting
disease prognosis and outcome, mainly persistent organ
failure and mortality and we compared these parameters
against each other.
Based on our results, NLR was found to be persistently higher
in the complicated group compared to non‑complicated
group which make it a useful tool in differentiating the
two groups early on admission. Furthermore, the NLR
showed significant correlation with disease severity over
time, making it an excellent tool to follow up on patients’
prognosis with normalisation of values in patients with
favourable prognosis and persistent elevation in those
with worse prognosis and persistent organ failure. Per our
results, the calculated cut‑point value for NLR was >10.5
which indicates a higher risk for complicated case.

and non‑complicated cases which make its clinical use of
limited value.
Haematocrit and platelet count were investigated as
independent prognostic factors to predict disease
severity and both showed significant change with time
but no significant difference between complicated and
non‑complicated cases.
These results show the high value of using simple, easily
accessible parameters available immediately on admission
to identify patients with higher risk of developing severe
AP, prolonged hospital stay and higher risk for persistent
organ failure and mortality which will help in directing
acute critical care earlier to prevent complications and
poor outcomes.
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